Skip to ContentSkip to Navigation
How to find us dr. G.M.P.J. (Gwenny) Verstappen

Publications

Abacept treatment for patients with early active primary Sjögren's syndrome: OPEN-LABEL EXTENSION PHASE OF A RANDOMIZED CONTROLLED PHASE III TRIAL

Abatacept treatment for patients with early active primary Sjogren's syndrome: a single-centre, randomised, double-blind, placebo-controlled, phase 3 trial (ASAP-III study)

Blocking T cell co-stimulation in primary Sjogren's syndrome: rationale, clinical efficacy and modulation of peripheral and salivary gland biomarkers

Blocking T cell co-stimulation in primary Sjögren's syndrome: rationale, clinical efficacy and modulation of peripheral and salivary gland biomarkers

COMPOSITE OF RELEVANT ENDPOINTS FOR SJOGREN'S SYNDROME (CRESS)

Composite of Relevant Endpoints for Sjogren's Syndrome (CRESS)

Gene expression profiling of epithelium-associated FcRL4(+) B cells in primary Sjogren's syndrome reveals a pathogenic signature

Identification of Clinically and Pathophysiologically Relevant Rheumatoid Factor Epitopes by Engineered IgG Targets

Repertoire Analysis of B-Cells Located in Striated Ducts of Salivary Glands of Patients With Sjogren's Syndrome

Role of interaction between B cells and epithelial cells in pSS: Correspondence

Read more